A recently developed and validated risk prediction scoring system predicted the likelihood of detecting advanced colorectal neoplasia in adults < 45 years of age based on tobacco use history, body ...
Researchers found that body mass index, family history of colorectal cancer, and tobacco use were identified as risk factors for advanced colorectal neoplasia in the training set. HealthDay News — A ...
Please provide your email address to receive an email when new articles are posted on . The American Gastroenterological Association published a clinical practice update to describe the role of ...
Sensitivity varied from 10.1 to 36.7%, and specificity varied from 85.5 to 96.6% for advanced colorectal neoplasia. HealthDay News — Fecal immunochemical tests (FITs) have variable sensitivity and ...
The stool-based test picks up colorectal cancers despite prior polypectomy, but many do not receive the recommended ...
Please provide your email address to receive an email when new articles are posted on . Multi-target stool DNA screening tests predicted neoplasia at follow-up colonoscopy more often than fecal ...
Across all ages, ADC incidence did not significantly vary, whereas NEN rates rose from 2004 to 2013, increasing between 10.1% (95% CI, 4.0%-16.5%) and 12.6% (95% CI, 7.2%-18.2%) per year before ...
Use of an electronic health record (iKnowMed), in conjunction with evidence-based pathways, for data capture and outcome measurement in colorectal cancer patients treated with first-line therapy in ...
Outcomes of IBD-associated colorectal cancer and implications in early-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium. This abstract ...
The objective of this study was to evaluate the potential beneficial effects of non-steroidal anti-inflammatory drugs (NSAIDs) and/or acetylsalicylic acid (ASA) and hormone replacement therapy (HRT) ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Colorectal ...
This randomized trial showed that a personalized message about colorectal cancer risk to patients and providers had no effect on screening uptake. However, stool testing rates were higher with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results